ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in ImageneBio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +5 vs. Q4 2022
- Shares held
- 25.0M
- −1.28M (−4.9%) vs. Q4 2022
- Total value
- $86.2M
- +$16.3M (+23.4%) vs. Q4 2022
- New holders
- 7
- 16 more added
- Sold out
- 2
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | 50 | $173 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 218 | $752 | 0.00% | +218 | New |
| Wells Fargo & Company | 273 | $942 | 0.00% | +3+1.1% | Added |
| Royal Bank of Canada | 265 | $1.00K | 0.00% | +265 | New |
| UBS Group AG | 624 | $2.15K | 0.00% | +624 | New |
| JPMorgan Chase & Co | 877 | $3.00K | 0.00% | 00.0% | Unchanged |
| Baystate Wealth Management LLC | 2,999 | $10.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,563 | $13.0K | 0.00% | −10,355−74.4% | Reduced |
| Citigroup Inc | 4,304 | $14.8K | 0.00% | +3,603+514.0% | Added |
| Bank of America Corp | 6,882 | $23.7K | 0.00% | −2,227−24.4% | Reduced |
| Charles Schwab Investment Management Inc | 12,066 | $41.6K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 13,301 | $45.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 13,488 | $46.5K | 0.00% | +9,819+267.6% | Added |
| Jacobs Levy Equity Management, Inc | 18,144 | $62.6K | 0.00% | +18,144 | New |
| Northern Trust Corp | 30,790 | $106.2K | 0.00% | +3,671+13.5% | Added |
| Goldman Sachs Group Inc | 35,192 | $121.4K | 0.00% | +35,192 | New |
| Jane Street Group, LLC | 38,318 | $132.2K | 0.00% | +38,318 | New |
| Cornercap Investment Counsel Inc | 39,461 | $136.1K | 0.02% | +9,996+33.9% | Added |
| Susquehanna International Group, LLP | 39,732 | $137.1K | 0.00% | +39,732 | New |
| Dimensional Fund Advisors LP | 41,439 | $143.4K | 0.00% | +12,757+44.5% | Added |
| State Street Corp | 59,953 | $206.8K | 0.00% | +9,200+18.1% | Added |
| Ensign Peak Advisors, Inc | 90,310 | $311.6K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 108,880 | $376.0K | 0.00% | +98,681+967.6% | Added |
| DAFNA Capital Management LLC | 112,936 | $389.6K | 0.12% | −9,581−7.8% | Reduced |
| Bridgeway Capital Management, LLC | 114,650 | $395.5K | 0.01% | +25,000+27.9% | Added |
| Citadel Advisors LLC | 180,097 | $621.3K | 0.00% | −1,975,037−91.6% | Reduced |
| Barclays PLC | 198,041 | $683.2K | 0.00% | −1,362−0.7% | Reduced |
| Geode Capital Management, LLC | 242,720 | $837.4K | 0.00% | +6,286+2.7% | Added |
| BlackRock Inc. | 307,234 | $1.06M | 0.00% | +1,818+0.6% | Added |
| Laurion Capital Management LP | 529,000 | $1.83M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 998,588 | $3.45M | 0.00% | +19,071+1.9% | Added |
| Artal Group S.A. | 1,549,513 | $5.35M | 0.32% | 00.0% | Unchanged |
| Verition Fund Management LLC | 1,595,941 | $5.51M | 0.09% | +15,566+1.0% | Added |
| CHI Advisors LLC | 1,660,872 | $5.73M | 1.52% | +23,500+1.4% | Added |
| Omega Fund Management, LLC | 2,249,123 | $7.76M | 5.06% | 00.0% | Unchanged |
| BVF Inc | 3,169,164 | $10.9M | 0.40% | +666,093+26.6% | Added |
| OrbiMed Advisors LLC | 3,186,166 | $11.0M | 0.22% | +252,225+8.6% | Added |
| FMR LLC | 3,313,385 | $11.4M | 0.00% | −411,190−11.0% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $17.3M | 2.34% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −17,606−100.0% | Sold out |